| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 557.9 | 564.1 | 533.2 |
| Other income | 2.0 | 5.9 | 0.7 |
| Total income | 559.9 | 570.0 | 534.0 |
| Profit before exceptional items & tax | -25.8 | 66.9 | -22.3 |
| Exceptional items | 0.0 | 3.4 | 0.0 |
| Profit before tax | -25.8 | 70.3 | -22.3 |
| Net profit | -19.3 | 52.9 | -16.0 |
| Operating margin | -4.6% | 12.3% | -4.2% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Revenue, year on year | +4.60% |
|---|---|
| Operating profit, year on year | -20.90% |
| Operating profit, quarter on quarter | -145.60% |
NSE results filing, NSE: GODAVARIB. Figures extracted from the filing.
Godavari Biorefineries Ltd: key numbers
- Share price
- ₹236.52
- Market cap
- ₹1,210 Cr
- Revenue (annual)
- ₹1,988 Cr
- Net profit (annual)
- ₹3.53 Cr
- P/E (TTM)
- 5374.2×Sector 37.5×
- Promoter holding
- 63.31%+0.00% QoQ
- FII holding
- 0.22%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Godavari Biorefineries Ltd
All →Godavari Biorefineries Legal & Regulatory
Godavari Biorefineries received a Rs. 12.88 Crore demand notice from HESCOM for cross-subsidy charges on power imported between 2013-2016. The company is assessing the liability.
- Value
- ₹12.88 Cr
Godavari Biorefineries Patent
China's patent office granted Godavari Biorefineries a patent for compounds treating viral infections. The invention covers V-ATPase inhibition for medicament use.
Godavari Biorefineries Business Update
Godavari Biorefineries Ltd has been granted a patent by the European Patent Office for its 'A Biofiller for Rubber Reinforcement' technology.
Godavari Biorefineries Annual Report
Godavari Biorefineries Limited submitted its 2025-26 Annual Report, prior to the 71st Annual General Meeting scheduled for September 28, 2026.
Godavari Biorefineries Annual General Meeting
Godavari Biorefineries Ltd issued the notice for its 71st Annual General Meeting, scheduled for September 28, 2026, via video conferencing.
Godavari Biorefineries Investor Presentation: Key Takeaways
Q1 FY27 revenue grew 4.6% to ₹557.9 Cr, but EBITDA fell to ₹2.6 Cr. Performance was pressured by high inventory costs and raw material prices despite strong chemical segment growth.